Published in
Elsevier, Annals of Oncology, (29), p. viii465, 2018
DOI: 10.1093/annonc/mdy289.059
Links
Tools
Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Journal article published in 2018 by
M. W. Rohaan,
T. H. Borch,
J. H. van den Berg,
M. H. Geukes Foppen,
M. Donia 
,
Ö. Met,
B. Nuijen,
M. van Zon,
E. A. M. Bakker,
R. de Boer,
L. M. Pronk,
S. Wilgenhof,
C. U. Blank,
J. V. van Thienen,
A. C. J. van Akkooi
and other authors.
,
Ö. Met,
B. Nuijen,
M. van Zon,
E. A. M. Bakker,
R. de Boer,
L. M. Pronk,
S. Wilgenhof,
C. U. Blank,
J. V. van Thienen,
A. C. J. van Akkooi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 